Catalent Pharma Solutions has completed the expansion of its facility in Aprilia, Italy, which was successfully inspected by the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA) last month. This expansion offers services from product conceptualization to formulation, development, production and packaging for prescription and OTC products. It also enhances European quality and analytical capabilities that include services such as market registration, analytical testing and market release by qualified persons.

“Expanding our drug delivery capabilities and expertise reinforces Catalent Aprilia’s position as a leading integrated development and delivery facility in Southern Europe,” said Stefano Arena, general manager of Catalent’s Aprilia site.

Catalent provides services for solubility, stability and bioavailability challenges for a wide range of liquid and semi-solid formulations.